Charles Schwab Investment Management Inc Twist Bioscience Corp Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Twist Bioscience Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 594,081 shares of TWST stock, worth $19.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
594,081
Previous 512,415 15.94%
Holding current value
$19.5 Million
Previous $20.1 Million 8.64%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$28.16 - $40.27 $2.3 Million - $3.29 Million
81,666 Added 15.94%
594,081 $21.9 Million
Q1 2025

Sep 15, 2025
SELL
$36.71 - $54.07 $3 Million - $4.42 Million
-81,666 Reduced 13.75%
512,415 $20.1 Million
Q1 2025

May 09, 2025
SELL
$36.71 - $54.07 $1.12 Million - $1.64 Million
-30,417 Reduced 5.6%
512,415 $20.1 Million
Q4 2024

Feb 06, 2025
BUY
$36.89 - $52.7 $659,962 - $942,803
17,890 Added 3.41%
542,832 $25.2 Million
Q3 2024

Nov 12, 2024
BUY
$36.72 - $58.88 $902,651 - $1.45 Million
24,582 Added 4.91%
524,942 $23.7 Million
Q2 2024

Aug 12, 2024
BUY
$27.95 - $53.0 $1.19 Million - $2.25 Million
42,425 Added 9.26%
500,360 $24.7 Million
Q1 2024

May 08, 2024
BUY
$32.28 - $41.5 $313,212 - $402,674
9,703 Added 2.16%
457,935 $15.7 Million
Q4 2023

Feb 06, 2024
BUY
$15.08 - $38.61 $86,378 - $221,158
5,728 Added 1.29%
448,232 $16.5 Million
Q3 2023

Nov 08, 2023
BUY
$18.62 - $26.57 $270,194 - $385,557
14,511 Added 3.39%
442,504 $8.97 Million
Q2 2023

Aug 09, 2023
BUY
$11.49 - $20.46 $58,185 - $103,609
5,064 Added 1.2%
427,993 $8.76 Million
Q1 2023

May 11, 2023
BUY
$14.6 - $30.9 $56,458 - $119,490
3,867 Added 0.92%
422,929 $6.38 Million
Q4 2022

Feb 13, 2023
BUY
$21.92 - $39.37 $197,784 - $355,235
9,023 Added 2.2%
419,062 $9.98 Million
Q3 2022

Nov 14, 2022
SELL
$33.44 - $56.56 $365,867 - $618,822
-10,941 Reduced 2.6%
410,039 $14.5 Million
Q2 2022

Aug 15, 2022
BUY
$26.2 - $54.0 $119,655 - $246,618
4,567 Added 1.1%
420,980 $14.7 Million
Q1 2022

May 13, 2022
BUY
$38.58 - $83.27 $2.05 Million - $4.43 Million
53,155 Added 14.63%
416,413 $20.6 Million
Q4 2021

Feb 11, 2022
BUY
$75.47 - $135.88 $656,362 - $1.18 Million
8,697 Added 2.45%
363,258 $28.1 Million
Q3 2021

Nov 16, 2021
BUY
$95.64 - $131.48 $3.41 Million - $4.69 Million
35,685 Added 11.19%
354,561 $37.9 Million
Q2 2021

Aug 16, 2021
BUY
$88.13 - $142.06 $464,797 - $749,224
5,274 Added 1.68%
318,876 $42.5 Million
Q1 2021

May 17, 2021
BUY
$105.48 - $207.97 $6.3 Million - $12.4 Million
59,773 Added 23.55%
313,602 $38.8 Million
Q4 2020

Feb 16, 2021
BUY
$76.64 - $167.89 $1.21 Million - $2.66 Million
15,842 Added 6.66%
253,829 $35.9 Million
Q3 2020

Nov 13, 2020
BUY
$45.46 - $78.79 $1.83 Million - $3.17 Million
40,218 Added 20.34%
237,987 $18.1 Million
Q2 2020

Aug 14, 2020
BUY
$26.4 - $45.3 $563,085 - $966,203
21,329 Added 12.09%
197,769 $8.96 Million
Q1 2020

May 15, 2020
BUY
$19.71 - $35.15 $688,036 - $1.23 Million
34,908 Added 24.66%
176,440 $5.4 Million
Q4 2019

Feb 07, 2020
BUY
$21.0 - $26.48 $125,160 - $157,820
5,960 Added 4.4%
141,532 $2.97 Million
Q3 2019

Nov 08, 2019
BUY
$23.72 - $33.99 $154,464 - $221,342
6,512 Added 5.05%
135,572 $3.24 Million
Q2 2019

Aug 09, 2019
BUY
$21.74 - $33.2 $2.12 Million - $3.24 Million
97,704 Added 311.6%
129,060 $3.75 Million
Q1 2019

May 14, 2019
BUY
$19.95 - $27.21 $88,518 - $120,730
4,437 Added 16.48%
31,356 $727,000
Q4 2018

Feb 14, 2019
BUY
$14.0 - $31.08 $376,866 - $836,642
26,919 New
26,919 $622,000

Others Institutions Holding TWST

# of Institutions
269
Shares Held
72.7M
Call Options Held
60.8K
Put Options Held
58K
View Full List

About Twist Bioscience Corp

TWST Quotes by TradingView
  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $1.85B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email